Product Details Form: Lyophilized powder Purity: 99% Research Application Overview This copper binding research compound, commonly known as GHK-Cu, is examined extensively in controlled in vitro environments
Any peptides discussed are research compounds and are not presented as products for human or veterinary use
10.1038/s41569-018-0030-z Summary Keywords D-Gal, endothelial cell senescence, FOXO4-DRI, P53, ROS Citation Hu Z, Li F, Hu C, Shan Q, Tang Z, Jiang M, Yi X, Chen X, Jin L, Wang X and Wang Y (2026) FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway
Why Choose GoalBMI Wellness for Peptide Therapy
It does not approve a clinical indication, dose, route, treatment duration, or combination